Ayalapharma
2 known investors
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Investors · 2
Frequently asked questions
- What does Ayalapharma do?
- Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
- Who are Ayalapharma's investors?
- Ayalapharma's investors include aMoon, Israel Biotech Fund.